Gary M. Ansel

MD, FACC

Dr. Gary M. Ansel

Interventional Cardiologist/ Cardiac and Peripheral Vascular Intervention Specialist

Positions
System Medical Chief, Vascular Program, OhioHealth
Assistant Clinical Professor of Medicine, University of Toledo Medical Center
Physician, OhioHealth Heart and Vascular Physician Group
Associate Director, OhioHealth Research Institute
Investigator, OhioHealth Research Institute
Professional Interests

Dr. Ansel is an active clinical consultant and proceduralist in all aspects of vascular medicine and cardiology. He has dedicated his career to facilitating a total vascular care program for patients.

Research and Collaboration
OrganizationRolePurposeCompensation
AbbottScientific and Strategic Advisory Board MemberDevelopment of advanced diagnostic and therapeutic medical systems for the treatment of vascular disease.Consulting Fees
AlucentConsultantConsultingConsulting Fees
BardConsultantConsultingConsulting Fees
Best DoctorsConsultantMedical diagnostic services.Consulting Fees
Boston ScientificConsultantConsultingConsulting Fees
Bryn Mawr CommunicationsConsultantConsultingConsulting Fees
Burpee MedSystemsConsultantConsultingNon-compensated
Capture VascularConsultantBench studies, animal studies, design iterations, post-market registry for new catheter.Consulting Fees/Equity
Case WesternConsultantConsultingConsulting Fees
ContegoConsultantConsultingConsulting Fees/Equity
Cook MedicalConsultantConsultingConsulting Fees
CSINational Principal InvestigatorClinical trial of orbital atherectomy system in treating peripheral arterial disease.Consulting Fees
GoreConsultantConsultingConsulting Fees
InnogestConsultantConsultingConsulting Fees
Lake RegionConsultantDevelopment of minimally-invasive delivery systems and components in stimulation therapy, cardiovascular, peripheral, neurovascular, and vascular access.Consulting Fees
MedtronicPeripheral Advisory Board and PreceptorDevelopment of medical devices for treatment of peripheral vascular disease.Consulting Fees
NovateConsultantDevelopment of bioabsorbable filters for the prevention of pulmonary embolism.Consulting Fees/Equity
ProvascularConsultantSpeakingNon-compensated
Quality Management Consulting Group, Ltd.ConsultantConsulting Peer Review ServicesConsulting Fees
ReFlowConsultantDevelopment of medical devices such as catheters to access discrete regions of the peripheral vasculature.Consulting Fees/Equity
SpectraneticsConsultantConsultingConsulting Fees
SurModicsConsultantMedical device coatingsConsulting Fees
SurModicsConsultantConsultingConsulting Fees
UpstreamConsultantPercutaneous transluminal catheters for retrograde angioplastyConsulting Fees
ValiantConsultantEquity
Vascular DynamicsData Safety and Monitoring Board ChairDevelopment of implants for the treatment of hypertension.Consulting Fees
VatrixScientific Advisory Board MemberDevelopment of balloon devices for the treatment of aneurysmal disease.Equity
VEINSAssociate DirectorProvide comprehensive education to cardiology field for treatment of venous diseaseConsulting Fees
Veryan Medical LimitedConsultantConsulting re Vascular StentsConsulting Fees/Equity
Professional Highlights
Publication (10/01/2014)

Two-Year Analysis of the Japanese Cohort From the Zilver PTX Randomized Controlled Trial Supports the Validity of Multinational Clinical Trials. Ohki T, Yokoi H, Kichikawa K, Kimura T, Snyder SA, Ragheb AO, O'Leary EE, Jaff MR, Ansel GM, Dake MD. J Endovasc Ther. 2014 Oct;21(5):644-53. doi: 10.1583/14-4753.1. PMID: 25290792 [PubMed - in process]

Publication (08/01/2013)

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM; VIBRANT Investigators. J Vasc Surg. 2013 Aug;58(2):386-95.e4. doi: 10.1016/j.jvs.2013.01.050. Epub 2013 May 13. PMID: 23676191 [PubMed - indexed for MEDLINE]

Patent (05/02/2007)

US Patent 7220269 B1: Thrombectomy catheter system with occluder and method of using same.

Biography

Dr. Ansel is an internationally renowned interventional expert, both in peripheral vascular and cardiovascular procedures. He serves as an invited faculty member at many of the largest cardiovascular conferences and medical meetings all over the world.

Dr. Ansel has been appointed Associate Medical Director of the OhioHealth Research and Innovation Institute in Columbus, Ohio and is a member of the OhioHealth Research Industry Council. He serves as a primary investigator for numerous national and international research trials helping to develop improved patient care to those suffering with peripheral and cardiovascular disease. Dr. Ansel hosts several industry sponsored training courses attended by national and international physicians.

Currently, he serves as System Medical Chief, Vascular Program - OhioHealth, and Assistant Clinical Professor of Medicine in the Department of Internal Medicine at the University Of Toledo Medical Center, Toledo, Ohio.

Dr. Ansel is a founding board member of the Vascular InterVentional Advances Conference (VIVA) which is a non-profit organization dedicated to the education and research of vascular disease.

Dr. Ansel received his medical degree from The Ohio State University College of Medicine where he also completed a postgraduate research fellowship in cardiology. He completed his residency and internship at the Medical University of Ohio in Toledo, Ohio and received his post-fellowship training in peripheral vascular intervention at the Ochsner Clinic in New Orleans.

Dr. Ansel is affiliated with OhioHealth Heart and Vascular Physicians in Columbus, Ohio. He is a former member of the Peripheral Vascular Committee for the American College of Cardiology and continues to serve as a member of several professional societies. He has contributed to journals such as The New England Journal of Medicine, Circulation, Journal of Endovascular Therapy, and The American Journal of Cardiology and has authored many medical book chapters.